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ABSTRACT
Introduction: This study aimed to vali-
date the SCOFF, an eating disorders (ED)
screening questionnaire, in a multiethnic
general population sample of adults.
Method: A two-stage design was
employed using the South East London
Community Health Study phases I and II
data. A total of 1,669 participants were
screened using the SCOFF in SELCoHI,
and 145 were administrated an ED clini-
cal interview in SELCoHII. We explored
the diagnostic validity of the question-
naire restricting to the 145 individuals
with the clinical questionnaire.
Results: Sensitivity and specificity of the
SCOFF were 53.7 and 93.5%, respectively.
Conclusion: The SCOFF showed good
levels of specificity but low sensitivity,
resulting in a high percentage of false
negatives. Given the low sensitivity
found in our sample the SCOFF is
likely to be a suboptimal measure for
the identification of ED in the com-
munity. VC 2014 The Authors Interna-
tional Journal of Eating Disorders
Published by Wiley Periodicals, Inc.
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Introduction
Eating disorders (ED) and other specified feeding
or eating disorders (OSFED) [the umbrella defini-
tion for subthreshold ED in the Diagnostic and Sta-
tistical Manual of mental disorders 5th ed (DSM-
5)] have a lifetime prevalence of up to 9%1 and are
associated with considerable physical and psychi-
atric comorbidity.2 However, ED are often unde-
tected in the general population resulting in small
proportions of individuals receiving treatment.3
The introduction of the SCOFF (an acronym
describing five key screening questions for ED,
which can be recalled through the mnemonic ‘Sick,
Control, One stone, Fat, Food’)4 as a screening tool
for ED in clinical settings has opened a window of
opportunity for extending its use to routine screen-
ings in the general population. The SCOFF has
been validated in a number of primary-care based
studies; in the UK4–7 and internationally;8–13 both
in written and oral delivery;14 and compared to
other instruments.15 Early studies have employed
clinical ED cases and controls,4,5,7 used mainly
female populations5,7,15–17 and few have included
individuals older than 40 years of age.6,16,18 Overall,
studies using clinical populations have yielded
higher values of sensitivity (Se) and specificity
(Sp)5,6,18 than community studies, the latter usually
finding higher Sp than Se.11–13
However, most validation studies in the commu-
nity have relied on young8,11 and homogeneous
populations6,12 (i.e., females, limited ethnic repre-
sentation), limiting the scope for the generalizability
of these results. Therefore, in order to investigate
the suitability of the SCOFF as both a screening tool
at the community level and in general population
surveys, we aimed to pilot a validation of the instru-
ment in a multiethnic population-based sample of
adults aged 16–90.
Method
Sample, Measures
This study employed data from the South East London
Community Health Study (SELCoH) I and II, a two-phase
This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which
permits use and distribution in any medium, provided the
original work is properly cited, the use is non-commercial and no
modifications or adaptations are made.
Accepted 12 November 2014
Additional Supporting Information may be found in the online
version of this article.
*Correspondence to: Francesca Solmi, Ph.D.; Behavioural and
Brain Science Unit, Institute of Child Health, 30 Guildford St, Lon-
don WC1N 1EH, United Kingdom
E-mail: francesca.solmi@ucl.ac.uk
1 Behavioural and Brain Sciences Unit, Institute of Child Health,
University College London, London, United Kingdom
2 Psychological Medicine, Institute of Psychiatry, King’s College
London, London, United Kingdom
3 Eating Disorders Unit, Institute of Psychiatry, King’s College
London, London, United Kingdom
Published online 12 December 2014 in Wiley Online Library
(wileyonlinelibrary.com). DOI: 10.1002/eat.22373
VC 2014 The Authors International Journal of Eating Disorders
Published by Wiley Periodicals, Inc.
312 International Journal of Eating Disorders 48:3 312–316 2015
general population survey of 1,669 individuals aged 161
living in the London (UK) boroughs of Lambeth and
Southwark. More details on the rationale, sampling, repre-
sentativeness, and assessment of participants in SELCoHI
is provided elsewhere.19 In SELCoHI, 1,669 participants
completed the SCOFF questionnaire and underwent
objective anthropometric measurements to calculate body
mass index (BMI). In SELCoHII, participants who had
given their consent to be re-contacted in SELCoHII and
did not need an interpreter (N5 1,560) were eligible for
inclusion in a clinical assessment of ED using the ED sec-
tion of the Structured Clinical Interview for DSM-IV Axis I
Disorders nonpatient edition (SCID-I-NP),20 if they: (i) had
screened positive at the SCOFF in SELCoHI (N5 158); or
(ii) had screened negative and had not screened positive
for other mental health conditions (N5 599). SCOFF posi-
tive participants were gender matched with a randomly
selected sample of eligible screen negatives.
Participants were asked for ED symptoms occurred at
the time of and since the SELCoHI assessment when
answering SCID-I questions. Despite referring to DSM-IV
diagnosis, the SCID-I also contains a section on binge eat-
ing disorder (BED), which means that all ED diagnoses
were explored. Moreover, interviewers did not apply the
‘skip-rules’ of the SCID-I in order to avoid underestimat-
ing the prevalence of diagnoses21 and gathered informa-
tion on type, frequency, and duration of ED behaviors in
order to be able to subsequently derive DSM5 diagnoses.
SELCoHI data was collected between June 2008 and
December 2010 and SELCoHII data between August 2011
and March 2013. Consent was collected prior to participa-
tion to the study.
Analyses
Sample characteristics were described using cross tabu-
lations and chi-square tests. Sensitivity, specificity, and
positive and negative predictive values (PPV, NPV) were
calculated on the sample interviewed in SELCoHII
(N5 145) using sampling weights accounting for: (i) pro-
portion of SCOFF positive and negative participants inter-
viewed with the SCID over the whole sample who
completed the SCOFF who agreed to take part to SELCoHII
(N total: 1,560; screen positive: 158; screen negative: 1402);
and (ii) proportion of ED diagnoses amongst screen posi-
tives and negatives, as previously recommended in two-
phase epidemiological studies.22 These weights account for
the real prevalence of the condition in the population
when circumstances do not allow maintaining adequate
sampling ratios, but do not account for characteristics
associated with participation at follow-up (e.g., age, gender,
and ethnicity). We weighted our data based on the sample
of the 1,560 participants who agreed to be followed up, on
the a priori knowledge that we could have not assessed the
real ED status of the remaining 109 participants with the
SCID-I and that limiting analyses to participants eligible
for inclusion (i.e., without mental health comorbidities,
common in individuals with ED) could have underesti-
mated the number of false negatives and, thus overesti-
mated the sensitivity. As a sensitivity analysis, we
calculated sensitivity and specificity using the whole initial
sample (N5 1,669) and the results did not change qualita-
tively (Se: 52.8; Sp: 93.7). Analyses were run in Stata12.
Results
Sample
Of the 322 participants who were eligible to take
part to the ED module (158 screen positive and 164
screen negatives), 89 (56.3%) participants who had
screened positive on the SCOFF and 88 (53.6%) of
those who screened negative were lost to follow up.
As seen in Supporting Information Table S1, no sys-
tematic differences existed between participants
who took part in the study and those who were lost
to follow-up with respect to age, marital status, eth-
nicity, education, and age. Among screen positive
participants, however, more obese (67%) and under-
weight (100.0%) participants were lost to follow-up.
A total of 145 participants [76 (46.3%) SCOFF
negative, 69 (43.7%) SCOFF positive] were assessed
using the SCID-I interview. Of these, 31 (21.4%)
received a threshold or subthreshold ED diagnosis.
The majority of participants were female (75%), of
White ethnicity (43%), between the ages of 25 and
34 years (28%), with a normal BMI (54%) and had
at least a General Certificate of Secondary Educa-
tion(GCSE) qualification (90%). No participant was
underweight (Table 1).
Diagnostic Validity
DSM5 diagnosis was correctly predicted by the
SCOFF for a total of 101 (69.7%; N5 73: no ED;
N5 28: ED) participants; 3 (2.0%) participants were
misclassified by the SCOFF as not having an ED
and 41 (28.3%) as having an ED. Two of the three
false negative participants had a diagnosis of binge
eating disorder (BED) and one of OSFED present-
ing with excessive exercise (not in table). All false
negatives were women, of White ethnicity, between
the ages of 35 and 54 and 60% were obese (Sup-
porting Information Table S2).
Based on the established cutoff of 2 positive
answers, the weighted sensitivity, specificity, PPV
and NPV of the SCOFF were 53.7 (95% CI: 36.2–
71.2), 93.5 (95% CI: 88.9–98.0), 40.6 (95% CI: 28.9–
53.1), and 96.1 (95% CI: 88.9–99.2), respectively.
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Discussion
This study aimed to assess the validity of the
SCOFF as a screening tool for ED in a multiethnic
general population sample of adults in London
(UK).
In line with previous general population studies,
we found that specificity of the instrument was
higher than its sensitivity, and that the latter was
lower than what previously found in some stud-
ies,11,12 but not others.13 All of these studies
employed a younger population than ours. PPV
was low, which is common for low prevalence con-
ditions, but NPV was high. Low sensitivity suggests
that high proportions of individuals with an ED are
not identified by the SCOFF.
Several factors could account for this finding. It is
possible that, in the absence of follow-up questions
(i.e., such as probing questions contained in the
SCID) the ego-syntonicity of ED could lead to nega-
tive answers. Moreover, the focus on the fat/thin
dichotomy in assessing body dissatisfaction could
introduce gender biases not accounting for different
cognitions in men23 or in individuals who are over-
weight or obese. Although the former were not rep-
resented amongst the participants who were false
negatives in our sample, two of the three of false
negatives were obese. More research using larger
mixed gender sample is warranted to test the valid-
ity of the SCOFF in men. The limited numbers of
questions contained in the SCOFF could also mean
that important behaviors (e.g., laxative use, exces-
sive exercise) central to the diagnosis of bulimia
nervosa or OSFED such as purging disorder, are
missed, as in the case of the participant presenting
with excessive exercise. Similarly, although we could
not provide evidence of this from our sample, it can
be speculated that without a measure of BMI, cases
of AN where the individual is stable on a low,
unhealthy BMI, could be missed as question 3 of
the SCOFF only enquires about recent weight loss.
Finally, the SCOFF was developed when BED was
not yet a recognized diagnosis and it is possible that
its questions are limited in identifying the condition,
which might be more prevalent in older adults, as
was the case amongst false negatives in our sample.
This could explain the lower sensitivity we found
compared to other community studies employing
younger participants.
This study has several strengths. It employed a
large representative and ethnically diverse general
population sample, suggesting that findings are gen-
eralizable to similarly diverse populations. Although
the validation was conducted on a subsample of
individuals (less than 10% of the full study popula-
tion), sampling weights were employed to account
for differential sampling across screen positives and
negatives to ensure that estimates of sensitivity and
specificity reflected the prevalence of ED in the
whole sample. However, some limitations should
also be accounted for. The SCID interview was con-
ducted 2–3 years following the administration of the
SCOFF; recall bias and regression to the mean could
thus have occurred to some extent. Since ED are
chronic conditions and no incident cases (i.e., new
ED onsets between the administration of the SCOFF
and the SCID) were found in interviews, we suggest
that the diagnoses were not greatly under- or over-
estimated and that false negatives could not be
attributed to ED cases with onset occurring after the
administration of the SCOFF. It is possible, however,
that different recall patterns could have occurred.
We tried to minimize this by asking about present
and past ED behaviors in general and then for their
duration in order to identify overlaps with the time
of the SCOFF interview. Interviewers were also
blinded as to the screening status of participants in
order to avoid observer bias. Substantial losses to
follow-up occurred and whilst the sample of screen
TABLE 2. Summary of weighted diagnostic validity
measures for the SCOFF questionnaire
Diagnostic Measures Values (95%CI)
Sensitivity 53.7 (36.2–71.2)
Specificity 93.5 (88.9–98.0)
Positive predictive value 40.6 (28.9–53.1)
Negative predicted value 96.1 (88.9–99.2)
TABLE 1. Socio-demographic characteristics of the
interviewed sample in SELCoHII
Socio-Demographic Characteristics N (%)
Total 145 (100)
Gender
Male 36 (24.8)
Female 109 (75.2)
Ethnicity
White 83 (57.2)
Black 42 (29)
Asian 4 (2.8)
Other 16 (11)
Education
No qualification 14 (9.7)
GCSE/A-level 70 (48.3)
Degree level or above 61 (42)
BMI
Underweight 0 (0)
Normal weight 75 (54.3)
Overweight 31 (22.5)
Obese 32 (23.2)
Age
16–24 38 (26.2)
25–34 41 (28.3)
35–44 23 (15.9)
45–54 26 (17.9)
55–64 9 (6.2)
651 8 (5.5)
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negative seems to be representative of the overall
sample (Supporting Information Table S1), 4 (100%)
underweight participants amongst the screen posi-
tives lost to follow-up could index missed ED cases
(especially AN) (Supporting Information Table S1).
Moreover, it appears that losses to follow-up in the
screen positive group could have occurred with
respect to participants of Asian and other ethnic
backgrounds (Supporting Information Table S1). This
could introduce some degree of selection bias, which
our sampling weights could not account for. How-
ever, given the small proportion and the lower weight
assigned to screen positive participants interviewed
compared to screen negatives, this is unlikely to bias
the overall sensitivity and specificity estimates.11,12
Only participants with no mental health comorbid-
ities were eligible to be assessed in SELCoHII and
were therefore interviewed. Although we weighted Se
and Sp to represent the whole sample that agreed to
be followed up, we could be overestimating or under-
estimating Se. On the one hand, as ED are comorbid
with a number of psychiatric conditions24 and more
false negatives could have occurred and been missed
in the noneligible sample. On the other hand, under-
estimation could also have occurred, as the false neg-
atives ratio was based on three individuals only and,
although weights were applied, uncertainty around
the estimate (reflected in the wide 95% CI) exists.
Future studies should aim at conducting both inter-
views simultaneously and on the whole sample to
improve accuracy of findings.
Recent studies found high levels of psychiatric
comorbidity in individuals who screened positive
on the SCOFF.25–27 Given its high specificity, this is
likely to reflect the high levels of psychopathology
in individuals with ED. However, although good at
ruling out an ED (i.e., high specificity) the SCOFF
should be used with caution as an ED screening
tool, as the low sensitivity in our sample indicates
that a substantial number of individuals with ED
might be missed. This is particularly relevant to
population-based samples and suggestions of
using the SCOFF as a screening tool in the commu-
nity.13 Based on our findings, more research is
needed to assess whether rephrasing some of its
questions could improve the diagnostic validity of
the SCOFF without compromising its brevity.
Moreover, research exploring the diagnostic valid-
ity of the SCOFF across different population sub-
groups (e.g., overweight and obese, males, ethnic
minorities) is warranted to improve the measure.
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